Fenofibrat

Fenofibrat
Klinički podaci
Prodajno ime	Ankebin, Antara, Elasterate, Elasterin
Drugs.com	Monografija
Način primene	Oralno
Farmakokinetički podaci
Poluvreme eliminacije	20 h
Izlučivanje	Renalno
Identifikatori
CAS broj	49562-28-9
ATC kod	C10AB05 (WHO)
PubChem	CID 3339
DrugBank	DB01039
ChemSpider	3222
KEGG	C07586
ChEBI	CHEBI:5001
ChEMBL	CHEMBL672
Hemijski podaci
Formula	C20H21ClO4
Molarna masa	360,831
	SMILES CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1; ;
	InChI InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3 ; Key:YMTINGFKWWXKFG-UHFFFAOYSA-N ;
Fizički podaci
Tačka topljenja	805 °C (1.481 °F)

Fenofibrat je organsko jedinjenje, koje sadrži 20 atoma ugljenika i ima molekulsku masu od 360,831 Da.^[1]^[2]^[3]^[4]

^ Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z: Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Clin Pharmacol Ther. 2004 Apr;42(4):212-7. PMID 15124979
^ Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005 Nov 26;366(9500):1849-61. PMID 16310551
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.